Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers

被引:11
|
作者
Kim, Woo Jung [1 ,2 ]
Lee, Sang Don [3 ]
Lee, Eun [2 ,4 ,5 ]
Namkoong, Kee [2 ,4 ]
Choe, Kang-Won [6 ]
Song, Joon Young [7 ]
Cheong, Hee Jin [7 ]
Jeong, Hye Won [8 ]
Heo, Jung Yeon [8 ]
机构
[1] Eulji Univ, Eulji Addict Inst, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea
[3] Armed Forces Capital Hosp, Dept Psychiat, Songnam, Gyeonggi, South Korea
[4] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea
[5] Severance Hosp, Sleep Hlth Ctr, Seoul, South Korea
[6] Armed Forces Capital Hosp, Dept Internal Med, Songnam, Gyeonggi, South Korea
[7] Korea Univ Coll Med, Dept Internal Med, Seoul, South Korea
[8] Chungbuk Natl Univ, Dept Internal Med, Cheongju, Chungbuk, South Korea
关键词
Narcolepsy; Incidence; H1N1 influenza A; Vaccination; Adjuvants; MF59; AUTOIMMUNE-DISEASE; ASSOCIATION; INFECTIONS; VACCINES;
D O I
10.1016/j.vaccine.2015.07.055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Previous reports mostly from Europe suggested an association between an occurrence of narcolepsy and an influenza A(H1N1)pdm09 vaccine adjuvanted with AS03 (Pandemrix (R)). During the 2009 H1N1 pandemic vaccination campaign, the Korean military performed a vaccination campaign with one type of influenza vaccine containing MF59-adjuvants. This study was conducted to investigate the background incidence rate of narcolepsy in South Korean soldiers and the association of the MF59-adjuvanted vaccine with the occurrence of narcolepsy in a young adult group. Methods: To assess the incidence of narcolepsy, we retrospectively reviewed medical records of suspicious cases of narcolepsy in 2007-2013 in the whole 20 military hospitals of the Korean military. The screened cases were classified according to the Brighton Collaboration case definition of narcolepsy. After obtaining the number of confirmed cases of narcolepsy per 3 months in 2007-2013, we compared the crude incidence rate of narcolepsy before and after the vaccination campaign. Results: We included 218 narcolepsy suspicious cases in the initial review, which were screened by the diagnostic code on the computerized disease registry in 2007-2013. Forty-one cases were finally diagnosed with narcolepsy in 2007-2013 (male sex, 95%; median age, 21 years). The average background incidence rate of narcolepsy in Korean soldiers was 0.91 cases per 100,000 persons per year. During the 9 months before vaccination implementation (April to December 2009), 6 narcolepsy cases occurred, whereas during the next 9 months (January to September 2010) including the 3-month vaccination campaign, 5 cases occurred. Conclusions: The incidence of narcolepsy in South Korean soldiers was not increased after the pandemic vaccination campaign using the MF59-adjuvanted vaccine. Our results suggest that the MF59-adjuvanted H1N1 vaccine did not contribute to the occurrence of narcolepsy in this young adult group. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4868 / 4872
页数:5
相关论文
共 50 条
  • [21] The 2015 influenza A (H1N1) pdm09 outbreak in India
    Murhekar, Manoj
    Mehendale, Sanjay
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 821 - 823
  • [22] A(H1N1) pdm09 influenza infection: vaccine inefficiency
    Friedman, Nehemya
    Drori, Yaron
    Pando, Rakefet
    Glatman-Freedman, Aharona
    Sefty, Hanna
    Bassal, Ravit
    Stein, Yaniv
    Shohat, Tamy
    Mendelson, Ella
    Hindiyeh, Musa
    Mandelboim, Michal
    ONCOTARGET, 2017, 8 (20) : 32856 - 32863
  • [23] Influenza A(H1N1)pdm09 during air travel
    Neatherlin, John
    Cramer, Elaine H.
    Dubray, Christine
    Marienau, Karen J.
    Russell, Michelle
    Sun, Hong
    Whaley, Melissa
    Hancock, Kathy
    Duong, Krista K.
    Kirking, Hannah L.
    Schembri, Christopher
    Katz, Jacqueline M.
    Cohen, Nicole J.
    Fishbein, Daniel B.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2013, 11 (02) : 110 - 118
  • [24] Assessment of the MF59-adjuvanted pandemic influenza A/H1N1 vaccine. Systematic review of literature
    Ruiz-Aragon, J.
    Grande Tejada, A. M.
    Marquez-Pelaez, S.
    Molina Linde, J. M.
    Yang, R.
    ANALES DE PEDIATRIA, 2013, 79 (04): : 208 - 217
  • [25] Structural Stability of Influenza A(H1N1)pdm09 Virus
    Yang, Hua
    Chang, Jessie C.
    Guo, Zhu
    Carney, Paul J.
    Shore, David A.
    Donis, Ruben O.
    Cox, Nancy J.
    Villanueva, Julie M.
    Klimov, Alexander I.
    Stevens, James
    JOURNAL OF VIROLOGY, 2014, 88 (09) : 4828 - 4838
  • [26] Seroprevalence of antibody to influenza A(H1N1) pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia
    McVernon, Jodie
    Laurie, Karen
    Faddy, Helen
    Irving, David
    Nolan, Terry
    Barr, Ian
    Kelso, Anne
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (02) : 194 - 200
  • [27] Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
    Simon, Marie
    Hernu, Romain
    Cour, Martin
    Casalegno, Jean-Sebastien
    Lina, Bruno
    Argaud, Laurent
    EMERGING INFECTIOUS DISEASES, 2013, 19 (06) : 1005 - 1007
  • [28] Influenza A(H1N1)pdm09 virus in pigs, Togo, 2013
    Ducatez, Mariette F.
    Awoume, Felix
    Webby, Richard J.
    VETERINARY MICROBIOLOGY, 2015, 177 (1-2) : 201 - 205
  • [29] Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients
    Son, Jungmin
    Lee, Soo Bong
    Lee, Dong Won
    Kim, Il Young
    Lee, Su Jin
    Lee, Sun Min
    Song, Sang Heon
    Seong, Eun Young
    Kwak, Ihm Soo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (02) : 275 - 283
  • [30] Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
    Ge, Pan
    Ross, Ted M.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 519 - 526